Human 4-1BB Ligand/TNFSF9 Biotinylated Antibody Summary
Arg71-Glu254
Accession # P41273
Applications
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Scientific Data
View Larger
Detection of 4‑1BB Ligand/TNFSF9 in Human Daudi cell line by Flow Cytometry. Human Daudi Burkitt lymphoma cell line was stained with Goat Anti-Human 4-1BB Ligand/TNFSF9 Biotinylated Polyclonal Antibody (Catalog # BAF2295, filled histogram) or control antibody (BAF108, open histogram), followed by PE-conjugated Streptavidin (F0040). Staining was performed usinig our Staining Membrane-associated Proteins protocol.
Reconstitution Calculator
Preparation and Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: 4-1BB Ligand/TNFSF9
4-1BB ligand (4-1BBL; also CD137L) is a 32 kDa type II transmembrane protein that belongs to the TNF superfamily (TNFSF) molecules (1‑4). The human 4-1BBL cDNA encodes a 254 amino acid (aa) protein that contains a 25 aa N-terminal cytoplasmic domain, a 23 aa transmembrane segment, and a 206 aa C-terminal extracellular region (5). The extracellular domain (ECD) of 4-1BBL has a jelly-roll, beta -sandwich tertiary structure that is similar to other TNFSF members. There is only one cysteine in the human ECD, and no potential N-linked glycosylation sites. The potential exists, however, for O-linked glycosylation. The human 4-1BBL ECD shares 32% and 35% aa identity with mouse and rat ECD, respectively. In the cytoplasmic domain, human 4-1BBL is 55 aa shorter than the equivalent region in rodents. 4-1BBL is expressed by activated B cells, macrophages, dendritic cells, activated T cells, neurons and astrocytes (2, 3, 6). A 26 kDa soluble form of 4-1BBL is known to occur in humans. Although it is presumably generated by MMP activity, its amino acid size is currently unreported (4). The soluble form is bioactive. Human 4-1BBL signals through both CD137/4-1BB and itself. Its cytoplasmic tail participates in reverse signaling that induces apoptosis in T cells and cytokine secretion (IL-6; TNF-alpha ) by monocytes (7, 8). 4-1BBL binding to CD137/4-1BB produces a number of effects. It seems to play a key role in the T cell recall response. It maintains T cell numbers at the end of a primary response, and induces CD4+ and CD8+ T cells to proliferate and secrete cytokines such as IL-2 and IFN-gamma in CD4+ cells, and IFN-gamma in CD8+ cells (9, 10).
- Kwon, B. et al. (2003) Exp. Mol. Med. 35:8.
- Salih, H.R. et al. (2002) Int. J. Clin. Pharmacol. Ther. 40:348.
- Vinay, D.S. and B.S. Kwon (1998) Semin. Immunol. 1:481.
- Salih, H.R. et al. (2001) J. Immunol. 167:4059.
- Alderson, M.R. et al. (1994) Eur. J. Immunol. 24:2219.
- Reali, C. et al. (2003) J. Neurosci. Res. 74:67.
- Michel, J. et al. (1999) Immunology 98:42.
- Langstein, J. et al. (1998) J. Immunol. 160:2488.
- Wen, T. et al. (2002) J. Immunol. 168:4897.
- Dawicki, W. and T.H. Watts (2004) Eur. J. Immunol. 34:743.
Product Datasheets
Citations for Human 4-1BB Ligand/TNFSF9 Biotinylated Antibody
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
2
Citations: Showing 1 - 2
Filter your results:
Filter by:
-
A human CD137�PD-L1 bispecific antibody promotes anti-tumor immunity via context-dependent T cell costimulation and checkpoint blockade
Authors: C Geuijen, P Tacken, LC Wang, R Klooster, PF van Loo, J Zhou, A Mondal, YB Liu, A Kramer, T Condamine, A Volgina, LJA Hendriks, H van der Ma, E Rovers, S Engels, F Fransen, R den Blanke, V Zondag-van, A Basmeleh, W Bartelink, A Kulkarni, W Marissen, CY Huang, L Hall, S Harvey, S Kim, M Martinez, S O'Brien, E Moon, S Albelda, C Kanellopou, S Stewart, H Nastri, ABH Bakker, P Scherle, T Logtenberg, G Hollis, J de Kruif, R Huber, PA Mayes, M Throsby
Nature Communications, 2021-07-21;12(1):4445.
Species: Human
Sample Types: Whole Cells
Applications: IHC -
Crystal structure of the human 4-1BB/4-1BBL complex
Authors: RN Gilbreth, VY Oganesyan, H Amdouni, S Novarra, L Grinberg, A Barnes, M Baca
J. Biol. Chem., 2018-05-02;0(0):.
Species: Human
Sample Types: Cell Lysates
Applications: Western Blot
FAQs
No product specific FAQs exist for this product, however you may
View all Antibody FAQsReviews for Human 4-1BB Ligand/TNFSF9 Biotinylated Antibody
Average Rating: 5 (Based on 1 Review)
Have you used Human 4-1BB Ligand/TNFSF9 Biotinylated Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Filter by:
